Table 2.
Clinical events through 5 years.
| At 1 year | From 1 to 5 years | |||||
|---|---|---|---|---|---|---|
| ACS | SCAD | P value | ACS | SCAD | P value | |
| All-cause death | 35 (5.5%) | 30 (2.4%) | <0.001 | 44 (9.1%) | 105 (10.0%) | 0.460 |
| Cardiac death | 25 (3.9%) | 15 (1.2%) | <0.001 | 18 (3.7%) | 32 (3.1%) | 0.373 |
| Myocardial infarction | 15 (2.4%) | 18 (1.5%) | 0.132 | 16 (3.3%) | 17 (1.8%) | 0.008 |
| Target vessel myocardial infarction | 11 (1.8%) | 9 (0.7%) | 0.039 | 7 (1.4%) | 10 (1.0%) | 0.227 |
| All-cause death or myocardial infarction | 47 (7.4%) | 47 (3.8%) | <0.001 | 56 (11.6%) | 118 (11.4%) | 0.706 |
| Ischemia-driven TLR | 18 (3.0%) | 33 (2.7%) | 0.682 | 13 (2.7%) | 31 (2.9%) | 0.864 |
| Target lesion failure | 47 (7.5%) | 53 (4.3%) | 0.003 | 32 (6.8%) | 64 (6.2%) | 0.514 |
| BARC bleeding | ||||||
| Type 3 | 8 (1.3%) | 12 (1.0%) | 0.498 | 7 (1.6%) | 26 (2.6%) | 0.085 |
| Type 5 | 0 (0.0%) | 3 (0.2%) | 0.229 | 2 (0.4%) | 3 (0.3%) | 0.705 |
| Stent thrombosis | ||||||
| Definite | 8 (1.3%) | 4 (0.3%) | 0.015 | 1 (0.2%) | 2 (0.2%) | 0.942 |
| Probable | 2 (0.3%) | 1 (0.1%) | 0.223 | 0 (0%) | 0 (0%) | NA |
| Definite or probable | 10 (1.6%) | 5 (0.4%) | 0.006 | 1 (0.2%) | 2 (0.2%) | 0.942 |
| Possible | 2 (0.3%) | 5 (0.4%) | 0.814 | 15 (1.5%) | 8 (1.6%) | 0.974 |
Note. Incidences of events were calculated by the Kaplan–Meyer method. Cumulative incidences were compared with the log-rank test. ACS: acute coronary syndrome; SCAD: stable coronary artery disease; TLR: target lesion revascularization; BARC: bleeding academic research consortium.